scholarly journals Income inequality and non-communicable disease mortality and morbidity in Brazil States: a longitudinal analysis 2002-2017

Author(s):  
Renato Simões Gaspar ◽  
Ludovico Rossi ◽  
Thomas Hone ◽  
André Zuanazzi Dornelles
The Lancet ◽  
2014 ◽  
Vol 384 (9941) ◽  
pp. 427-437 ◽  
Author(s):  
Vasilis Kontis ◽  
Colin D Mathers ◽  
Jürgen Rehm ◽  
Gretchen A Stevens ◽  
Kevin D Shield ◽  
...  

2020 ◽  
Vol 105 (11) ◽  
pp. 1055-1060 ◽  
Author(s):  
Joseph Lloyd Ward ◽  
Ingrid Wolfe ◽  
Russell M Viner

ObjectiveTo compare cause-specific UK mortality in children and young people (CYP) with EU15+ countries (European Union countries pre-2004, Australia, Canada and Norway).DesignMortality estimates were coded from the WHO World Mortality Database. Causes of death were mapped using the Global Burden of Disease mortality hierarchy to 22 cause groups. We compared UK mortality by cause, age group and sex with EU15+ countries in 2015 (or latest available) using Poisson regression models. We then ranked the UK compared with the EU15+ for each cause.SettingThe UK and EU15+ countries.ParticipantsCYP aged 1–19.Main outcome measureMortality rate per 100 000 and number of deaths.ResultsUK mortality in 2015 was significantly higher than the EU15+ for common infections (both sexes aged 1–9, boys aged 10–14 and girls aged 15–19); chronic respiratory conditions (both sexes aged 5–14); and digestive, neurological and diabetes/urological/blood/endocrine conditions (girls aged 15–19). UK mortality was significantly lower for transport injuries (boys aged 15–19). The UK had the worst to third worst mortality rank for common infections in both sexes and all age groups, and in five out of eight non-communicable disease (NCD) causes in both sexes in at least one age group. UK mortality rank for injuries in 2015 was in the top half of countries for most causes.ConclusionsUK CYP mortality is higher than a group of comparable countries for common infections and multiple NCD causes. Excess UK CYP mortality may be amenable to health system strengthening.


Author(s):  
Theodore Dharma Tedjamartono

Cancer is a non-communicable disease with high mortality and morbidity rates. Data recorded by GLOBOCAN in 2018 shows the number of cancer patients is reached 18 million people with a death rate of 9 million people and predicted to increase every year. Diabetes is known to affect morbidity and mortality in cancer patients through increasing cancer cell proliferation and the risk of metastasis. This literature study not only explains the epidemiology, but also the mechanisms underlying the association of diabetes to cancer in general. Literature search was done using four search engines from PubMed, ProQuest, Science Direct and Google Scholar in the last 5 year, but relevant older articles were included. Cancer occurs due to the carcinogenesis process. This process is complex, where normal cells do not immediately mutate and become cancer cells but through several stages. The possible mechanisms underlying carcinogenesis in diabetic patients are hyperglycaemia, hyperinsulinemia, chronic inflammation, genetic variation, obesity, and hyperlactatemia. Examination of sugar levels in cancer patients, as well as cancer screening in patients with diabetes need to be done to detect early events and reduce morbidity and mortality.


2016 ◽  
Vol 106 (5) ◽  
pp. 477 ◽  
Author(s):  
Beatrice Nojilana ◽  
Debbie Bradshaw ◽  
Victoria Pillay-van Wyk ◽  
William Msemburi ◽  
Ria Laubscher ◽  
...  

2012 ◽  
Vol 18 (2) ◽  
pp. 130-140 ◽  
Author(s):  
Chaisiri Angkurawaranon ◽  
Nisit Wattanatchariya ◽  
Pat Doyle ◽  
Dorothea Nitsch

2014 ◽  
Vol 7 (1) ◽  
pp. 25365 ◽  
Author(s):  
P. Kim Streatfield ◽  
Wasif A. Khan ◽  
Abbas Bhuiya ◽  
Syed M.A. Hanifi ◽  
Nurul Alam ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document